Shaheen A .2017 .Comprehensive review of keloid formation. Clin Res Dermatol, 4(5) : 1-8.
Wang ZC,Zhao WY,Cao Y,Liu YQ,Sun Q,Shi P .2020 .The roles of in ammation in keloid and hypertrophic scarsF. ront Immunol, 603187 : 603187.
Goutos I,Ogawa R .2017 .Steroid tape: A promising adjunct to scar management. Scars Burn Heal, 10 : 205951311.
Coppola MM,Salzillo R,Segreto F .2018 .Triamcinolone acetonide intralesional injection for the treatment of keloid scars: Patient selection and perspectives. Clin Cosmet Investig Dermatol, 10 : 387-96.
Chicharro-Alcantara D,Rubio-Zaragoza M,Damia-Gimenez E,Carrillo-Poveda JM,Cuervo-Serrato B,Pelaez-Gorrea P .2018 .Platelet-rich plasma: New insights for cutaneous wound healing management. J Funct Biomater, 10(1) : 10.
Klosova H,Stetinsky J,Bryjova I,Hledik S .2013 .Objective evaluation of the e ect of autologous platelet concentrate on post-operative scarring in deep burns. Burns, 01(6) : 1263-76.
Obolenskiy VN,Ermolova DA,Laberko LA,Semenova TV LA .2014 .E cacy of platelet-rich plasma for the treatment of chronic wounds. EWMA J, 14(1) : 37-41.
Kim DH,Je YJ,Kim CD,Lee YH,Seo YJ,Lee JH .2011 .Can platelet-rich plasma be used for skin rejuvenation? Evaluation of e ects of platelet-rich plasma on human dermal broblast. Ann Dermatol, 23(4) : 424-31.
Zhang M,Park G,Zhou B,Luo D .2018 .Applications and e cacy of platelet-rich plasma in dermatology: A clinical review. J Cosmet Dermatol, 10(5) : 660-5.
Zhang X,Zhang C,Ren H C .2020 .Comparison of triamcinolone acetonide and platelet-rich plasma for keloid treatment: A randomized controlled trial. Int J Dermatol, 1730742(3) : 343-50.
Kim YJ,Lee WJ,Lee SJ .2019 .The e cacy of combining plateletrich plasma with triamcinolone acetonide for the treatment of keloids: A clinical trial. Plast Reconstr Surg, 143(1) : 25-33.
Faghih Z,Ebrahimi T,Saki N. .2022 .Role of platelet-rich plasma in treating keloid scars: A clinical study. Dermatol Ther, 35(1) : e15291.
Wang X,Jiang H,Li Y,Li Y,Li J,Li H .2023 .E ects of plateletrich plasma combined with corticosteroids on hypertrophic scars and keloids: A clinical and molecular study. J Cosmet Dermatol, 22(2) : 487-94.
Park JH,Lee SY,Lee KS,Kim JY,Lee SJ,Kim WS .2020 .Molecular mechanisms underlying the e ects of platelet-rich plasma combined with corticosteroids in keloid treatment. Exp Dermatol, 29(8) : 786-94.
Lee JS,Kim HK,Park YK,Kim BJ,Kim MN,Kang H .2022 .Long-term outcomes of keloid treatment with intralesional triamcinolone acetonide and platelet-rich plasma: A randomized controlled trial. Dermatol Surg, 48(1) : 45-52.
Alharbi M,Awad A,El-Sayed M. .2021 .The impact of platelet-rich plasma on scar elasticity and patient satisfaction in keloid treatment: A prospective study. Aesthetic Plast Surg, 45(6) : 1589-96.
Kumar S,Singh K,Khosla A .2023 .E cacy of platelet-rich plasma in reducing keloid recurrence when combined with intralesional triamcinolone: A controlled study. J Cosmet Dermatol, 22(1) : 78-85.
Sagheer A,Shehzad A,Hussain I .2016 .Comparison of e cacy of intralesional 5- uorouracil alone versus intralesional triamcinolone acetonide with 5- uorouracil in small keloids. J Pak Assoc Dermatol, 26(4) : 361-5.